Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

18.26 -0.32 (-1.72%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,089,088
Open 18.77
Bid (Size) 18.23 (1)
Ask (Size) 18.47 (1)
Prev. Close 18.58
Today's Range 18.22 - 18.77
52wk Range 18.22 - 32.43
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023
Via Benzinga
First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology
From Organon & Co.
Via Business Wire

Performance

YTD
-34.95%
-34.95%
1 Month
-16.70%
-16.70%
3 Month
-9.78%
-9.78%
6 Month
-16.47%
-16.47%
1 Year
-30.54%
-30.54%

More News

Read More
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Via The Motley Fool
Stock Analysis: Organon & Co.
Via Talk Markets
Organon Bolsters Research & Development Expertise with Two Leadership Appointments
From Organon & Co.
Via Business Wire
3 Undervalued Healthcare Stocks In 2023
Via Talk Markets
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Organon Reports Results for the Second Quarter Ended June 30, 2023
From Organon & Co.
Via Business Wire
5 Value Stocks In The Healthcare Sector
Via Benzinga
Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar
From Samsung Bioepis
Via GlobeNewswire
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
Via The Motley Fool
Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades'
Via Benzinga
Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023
From Organon & Co.
Via Business Wire
REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
From Organon
Via Business Wire
3 S&P 500 Stocks to Own for the Next 50 Years
Via InvestorPlace
Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
From Organon & Co.
Via Business Wire
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
Via The Motley Fool
Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals
From Organon & Co.
Via Business Wire
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health
From Organon & Co.
Via Business Wire
7 Stocks That Are Long Overdue for a Relief Rally
Via InvestorPlace
Daily Stock Analysis: Organon & Co
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.